NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / COVAXIN gets WHO approval for emergency use listing
    COVAXIN gets WHO approval for emergency use listing
    1/6
    India 2 min read

    COVAXIN gets WHO approval for emergency use listing

    By Sagar
    Nov 03, 2021
    06:09 pm
    COVAXIN gets WHO approval for emergency use listing
    The Technical Advisory Group of WHO has recommended Indian shot COVAXIN.

    The World Health Organization (WHO) on Wednesday granted Emergency Use Listing (EUL) to COVAXIN. The Technical Advisory Group of WHO made the recommendation earlier in the day. COVAXIN is India's first indigenous vaccine against the coronavirus and is one of the six vaccines that have been approved by the country's drug regulator. Here are more details on this.

    2/6

    WHO confirms the news

    "WHO has granted emergency use listing (EUL) to COVAXIN (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19," according to an official statement from the global health body.

    3/6

    Why does it matter?

    COVAXIN's nod will help the vaccine gain wider acceptance around the world. It will allow its developer Bharat Biotech to start widely exporting the vaccine and let people fully vaccinated with the jab travel abroad without facing quarantine and other restrictions. Notably, many Indians, especially students who received this vaccine, have been facing issues in traveling abroad.

    4/6

    Bharat Biotech's long wait for approval

    Bharat Biotech had submitted the request for WHO's emergency use approval on April 19, meaning the process took more than six months. Last month, the WHO had held several meetings to discuss COVAXIN's approval. However, the global health body had sought more technical data from the company to conduct a final "risk-benefit assessment."

    5/6

    COVAXIN is 78% effective

    COVAXIN is India's second most prevalent coronavirus vaccine and has been found nearly 78% effective. It has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research's (ICMR) National Institute of Virology (NIV). As of November 3, over 12 crore doses of COVAXIN have been administered to the eligible population across India.

    6/6

    8 vaccines approved by WHO

    With the latest nod, WHO has given its EUL to eight COVID-19 vaccines. They include the Pfizer-BioNTech vaccine, Johnson and Johnson's (J&J) vaccine, two versions of the Oxford-AstraZeneca vaccine, Moderna's shot, and China's Sinopharm and Sinovac vaccines. The EUL is a risk-based procedure that considers vaccines for assessment and listing. The process also includes therapeutics and in-vitro diagnostics.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    World Health Organization
    Bharat Biotech
    COVAXIN

    World Health Organization

    Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers India
    COVAXIN under review; may get WHO recommendation in 24 hours COVID-19
    When will the COVID-19 pandemic end? WHO chief says this Tedros Adhanom Ghebreyesus
    Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO India

    Bharat Biotech

    COVAXIN recommended by expert panel for children aged 2-18 years Health & Wellness
    COVAXIN trial data for children aged 2-18 submitted to DCGI World Health Organization
    Decision on EUL of COVAXIN in October, says WHO World Health Organization
    COVAXIN for children: Bharat Biotech completes Phase 2/3 trials COVID-19

    COVAXIN

    Vaccination for children can wait as trial still underway: Expert COVID-19
    WHO expert panel to discuss COVAXIN approval in meet today World Health Organization
    India administers over 1 crore COVID-19 vaccines for 5th time Mansukh Mandaviya
    Bharat Biotech awaits feedback from WHO for COVAXIN's EUL World Health Organization
    Next News Article

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023